SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $279,000 | -71.5% | 76,707 | -34.9% | 0.00% | -75.0% |
| Q3 2019 | $978,000 | +0.7% | 117,876 | +4.6% | 0.02% | 0.0% |
| Q2 2019 | $971,000 | +236.0% | 112,683 | +316.2% | 0.02% | +166.7% |
| Q1 2019 | $289,000 | +8.6% | 27,075 | -10.8% | 0.01% | 0.0% |
| Q4 2018 | $266,000 | -74.7% | 30,365 | -51.5% | 0.01% | -70.0% |
| Q3 2018 | $1,050,000 | -22.9% | 62,545 | -3.6% | 0.02% | -39.4% |
| Q2 2018 | $1,361,000 | +24.6% | 64,913 | -4.3% | 0.03% | +26.9% |
| Q1 2018 | $1,092,000 | -59.9% | 67,830 | -52.8% | 0.03% | -62.9% |
| Q4 2017 | $2,723,000 | +56.3% | 143,712 | +16.1% | 0.07% | +66.7% |
| Q3 2017 | $1,742,000 | +83.4% | 123,826 | -2.9% | 0.04% | +68.0% |
| Q2 2017 | $950,000 | +49.1% | 127,508 | +30.1% | 0.02% | +47.1% |
| Q1 2017 | $637,000 | +117.4% | 98,025 | +48.2% | 0.02% | +88.9% |
| Q4 2016 | $293,000 | +597.6% | 66,159 | +637.1% | 0.01% | +350.0% |
| Q3 2016 | $42,000 | -17.6% | 8,975 | +16.2% | 0.00% | -33.3% |
| Q2 2016 | $51,000 | +13.3% | 7,726 | +10.9% | 0.00% | +50.0% |
| Q1 2016 | $45,000 | -6.2% | 6,964 | -12.4% | 0.00% | 0.0% |
| Q4 2015 | $48,000 | +4.3% | 7,954 | +3.5% | 0.00% | 0.0% |
| Q3 2015 | $46,000 | -2.1% | 7,687 | +10.3% | 0.00% | 0.0% |
| Q2 2015 | $47,000 | -48.4% | 6,969 | -53.6% | 0.00% | -33.3% |
| Q1 2015 | $91,000 | -4.2% | 15,031 | +9.7% | 0.00% | -25.0% |
| Q4 2014 | $95,000 | -3.1% | 13,706 | +12.9% | 0.00% | 0.0% |
| Q3 2014 | $98,000 | +38.0% | 12,140 | +38.5% | 0.00% | +33.3% |
| Q2 2014 | $71,000 | -30.4% | 8,765 | -32.7% | 0.00% | 0.0% |
| Q1 2014 | $102,000 | -19.7% | 13,025 | -9.1% | 0.00% | -25.0% |
| Q4 2013 | $127,000 | +149.0% | 14,324 | +136.6% | 0.00% | +100.0% |
| Q3 2013 | $51,000 | +18.6% | 6,055 | +3.6% | 0.00% | +100.0% |
| Q2 2013 | $43,000 | – | 5,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |